Hard Evidence for Second-Line Chemo in Gastric Cancer
Dr. David Kerr reports on a Korean meta-analysis that clearly supports use of second-line chemotherapy in locally advanced or metastatic gastric cancer at the time of relapse.
Source: Medscape Gastroenterology Podcast - Category: Gastroenterology Authors: Medscape Source Type: podcasts
More News: Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Podcasts